XML 28 R4.htm IDEA: XBRL DOCUMENT v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenues:    
Total revenues $ 3,546,669 $ 6,591,080
Operating expenses:    
Research and development 11,799,154 13,467,845
General and administrative 4,184,806 4,241,607
Loss on early termination of vendor agreement 453,135  
Total operating expenses 16,437,095 17,709,452
Loss from operations (12,890,426) (11,118,372)
Other income:    
Interest income 594,206 437,010
Other income 117,444  
Loss from operations before income taxes (12,178,776) (10,681,362)
Income tax (benefit) expense (15,156) 49,953
Net loss $ (12,163,620) $ (10,731,315)
Net earnings (loss) per share:    
Net loss per share, basic (in dollars per share) $ (0.79) $ (1.19)
Net loss per share, diluted (in dollars per share) $ (0.79) $ (1.19)
Weighted average number of common shares outstanding:    
Basic (in shares) 15,310,308 8,980,207
Diluted (in shares) 15,310,308 8,980,207
Grant income    
Revenues:    
Total revenues $ 3,546,669 $ 6,591,080